RMTI logo

Rockwell Medical, Inc. Stock Price

NasdaqCM:RMTI Community·US$38.2m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

RMTI Share Price Performance

US$1.08
-2.81 (-72.24%)
73.0% undervalued intrinsic discount
US$4.00
Fair Value
US$1.08
-2.81 (-72.24%)
73.0% undervalued intrinsic discount
US$4.00
Fair Value
Price US$1.08
AnalystConsensusTarget US$4.00
AnalystHighTarget US$5.00
AnalystLowTarget US$3.00

RMTI Community Narratives

AnalystConsensusTarget·
Fair Value US$4 73.0% undervalued intrinsic discount

Dialysis Demand Will Grow Despite Margin And Market Challenges

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AnalystHighTarget·
Fair Value US$5 78.4% undervalued intrinsic discount

Aging And Home Care Trends Will Raise Demand Amid Risks

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystLowTarget·
Fair Value US$3 64.0% undervalued intrinsic discount

Dialysis Loss Will Squeeze Margins Yet Yield Cautious Relief

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Snowflake Analysis

Flawless balance sheet and good value.

4 Risks
2 Rewards

Rockwell Medical, Inc. Key Details

US$88.0m

Revenue

US$72.6m

Cost of Revenue

US$15.4m

Gross Profit

US$18.0m

Other Expenses

-US$2.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 12, 2025
-0.074
17.52%
-2.90%
30.6%
View Full Analysis

About RMTI

Founded
1996
Employees
244
CEO
Mark Strobeck
WebsiteView website
www.rockwellmed.com

Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, centrisol and renasol hemodialysis concentrates, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. Its hemodialysis concentrate products are used to sustain patient’s life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The company serves to hemodialysis clinics, including dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Recent RMTI News & Updates

Why Investors Shouldn't Be Surprised By Rockwell Medical, Inc.'s (NASDAQ:RMTI) 32% Share Price Plunge

Oct 12
Why Investors Shouldn't Be Surprised By Rockwell Medical, Inc.'s (NASDAQ:RMTI) 32% Share Price Plunge

Recent updates

No updates